StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

EBS — Emergent BioSolutions Inc.

EXPENSIVE (MOS -164.9%) · Quality 19/100

Value Score 30 days ago: -4.9 → today -3.8

Price
6.04
Intrinsic value
2.28
Margin of safety
-164.9%
Implied growth (reverse DCF)
+24.6%
model assumes +6.0%
Value Score
-3.8
Quality
19
Psychology
14.2
Discovery
6.9
price/volume attention only
Moat score
28
erosion: none

Value Score: bottom 3% of Russell 3000 · Quality: bottom 10%

Open the interactive Deep Dive for EBS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/EBS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is EBS undervalued?

As of 2026-11-11, EBS trades at 6.04 against a computed intrinsic value of 2.28 (-164.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Emergent BioSolutions Inc.'s Value Score?

Emergent BioSolutions Inc.'s Value Score is -3.8 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.